Los Angeles, CA -- February 10, 2026 -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-enhanced enzymes transforming abundant feedstock into valuable nutraceuticals and new medicines - announced the launch of a redesigned corporate website and updated visual identity, reflecting the company’s refined strategic focus on pharmaceutical and nutraceutical markets.
.png?width=1024&height=1024&name=EXOZ_logo(powered).png)
